International ID
Conference Coverage
In the reemergence of typhus, the challenge is early diagnosis
SAN DIEGO – Doxycycline is the drug of choice for almost all of the rickettsial infections.
Conference Coverage
IDWeek 2017 opens in San Diego
The IDWeek 2017 symposia, oral abstract sessions, and poster abstract sessions are the highlights.
News
FDA approves single-dose, oral bacterial vaginosis treatment
Secnidazole is a next-generation 5-nitroimidazole antibiotic.
Opinion
Climate change may lead to more cellulitis
Since bacteria and fungi often thrive in warm, moist environments, warmer weather plays a role in higher rates of cellulitis.
Conference Coverage
Postpartum sepsis risk persists after 6 weeks
PARK CITY, UTAH – The findings help identify a group of women who are likely to need especially close follow-up after delivery.
From the Journals
Bezlotoxumab may lower risk of C. difficile readmissions
A phase 3 drug trial shows promise for high-risk recurrent CDI patients after discharge.
News
FDA grants accelerated approval for treatment of Chagas disease in children
Benznidazole, an antiparasitic drug, is the first treatment approved in the United States for treating the infection.
Conference Coverage
Role of fidaxomicin for C. difficile infection continues to evolve
The role of fidaxomicin for treating mild to moderate <i>Clostridium difficile</i> infection is still finding its way.
Conference Coverage
VIDEO: How to catch postpartum necrotizing fasciitis in time
Look for pain that seems out of proportion to the clinical signs.
From the Journals
Zika linked to a spectrum of neuroinflammatory diseases
Hospitalized patients with new-onset acute neuroinflammatory disease have their serum and cerebrospinal fluid prospectively analyzed for the virus...
From the Journals
Repeat blood cultures not useful in treating Gram-negative bacteremia
Follow-up blood cultures rarely provide useful clinical information in patients who are being treated for Gram-negative bacteremia.